Patents by Inventor REED J. HARRIS

REED J. HARRIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20230416401
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: February 9, 2023
    Publication date: December 28, 2023
    Applicant: Genentech, Inc.
    Inventors: Reed J. HARRIS, Paul MOTCHNIK
  • Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
    Patent number: 11597776
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: March 7, 2023
    Assignee: Genentech, Inc.
    Inventors: Reed J Harris, Paul A. Motchnick
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20220363780
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: July 27, 2022
    Publication date: November 17, 2022
    Applicant: Genentech, Inc.
    Inventors: Reed J. HARRIS, Paul A. MOTCHNICK
  • Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
    Patent number: 11414498
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: August 16, 2022
    Assignee: Genentech, Inc.
    Inventors: Reed J Harris, Paul A. Motchnick
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20190322761
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: July 3, 2019
    Publication date: October 24, 2019
    Applicant: Genentech, Inc.
    Inventors: Reed J Harris, Paul A. Motchnick
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20170174785
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: March 6, 2017
    Publication date: June 22, 2017
    Applicant: Genentech, Inc.
    Inventors: Reed J Harris, Paul A. Motchnick
  • Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
    Patent number: 9181346
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: November 10, 2015
    Assignee: Genentech, Inc.
    Inventors: Reed J. Harris, Paul A. Motchnik
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20140186867
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: January 23, 2014
    Publication date: July 3, 2014
    Applicant: Genentech, Inc.
    Inventors: REED J. HARRIS, PAUL A. MOTCHNIK
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20140186343
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: January 23, 2014
    Publication date: July 3, 2014
    Applicant: Genentech, Inc.
    Inventors: REED J. HARRIS, PAUL A. MOTCHNIK
  • Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
    Patent number: 8652474
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: February 18, 2014
    Assignee: Genentech, Inc.
    Inventors: Reed J. Harris, Paul A. Motchnik
  • ANTIBODIES WITH ENHANCED ADCC FUNCTIONS
    Publication number: 20110039300
    Abstract: The present invention concerns antibodies with enhanced antibody-dependent cell mediated cytotoxicity (ADCC) and method for preparation thereof.
    Type: Application
    Filed: August 6, 2010
    Publication date: February 17, 2011
    Inventors: ROBERT BAYER, Amy Shen, Reed J. Harris, Domingos Ng
  • ANTIBODIES WITH ENHANCED ADCC FUNCTION
    Publication number: 20110003338
    Abstract: The present invention concerns antibodies enhanced antibody-dependent cell mediated cytotoxicity (ADCC) and method for preparation thereof.
    Type: Application
    Filed: March 11, 2009
    Publication date: January 6, 2011
    Inventors: Robert Bayer, Reed J. Harris, Feng Li, Domingos Ng, Efren Pacis, Amy Shen, Marcella Yu
  • COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
    Publication number: 20090202546
    Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.
    Type: Application
    Filed: January 28, 2009
    Publication date: August 13, 2009
    Applicant: Genentech, Inc.
    Inventors: REED J. HARRIS, PAUL A. MOTCHNIK